Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity

Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity appeared first on…

Read More

Guía para encontrar seguro de salud a los 26

Se suponía que iba a ser más fácil. Cuando la Ley de Cuidado de Salud a Bajo Precio (ACA) se aprobó en marzo de 2010, el objetivo era ayudar a que más personas en el país obtuvieran seguro médico. Y, de hecho, la creación de mercados en línea y la ampliación de los criterios de…

Read More

CDC Vaccine Panel Ends Universal Hepatitis B Recommendation and Reviews Aluminum in Vaccines, Plus Public Awareness of Mifepristone Safety — The Monitor

This volume shares updates from the most recent CDC advisory panel meeting, changes to the CDC webpage on autism and vaccines, and polling on trust in news organizations. Additionally, it shares recent developments in AI and social media policy and new KFF poll findings about perceptions of mifepristone’s safety and prevalence.

Read More

Miriam Paramore, RxUtility

In this quickbite interview recorded at the Feb 2026 VIVE conference, I am talking with Miriam Paramore. Miriam is building RxUtility, which is helping consumers access the lowest drug prices at the point of dispensing. That means BOTH bringing in all those manufacturers coupons and getting the lowest cash prices. How does it work? Why…

Read More